Alventosa Abril Enric 4
4 · Freightos Ltd · Filed Jun 1, 2026
Research Summary
AI-generated summary of this filing
Freightos (CRGO) CTO Enric Alventosa Sells 2,904 Shares
What Happened
Enric Alventosa, Chief Technology Officer of Freightos Ltd (CRGO), reported a sale of 2,904 ordinary shares on May 28, 2026. The shares were disposed at $2.05 each for total proceeds of approximately $5,953. The transaction was reported on a Form 4 filed June 1, 2026.
Key Details
- Transaction date and price: 2026-05-28, sale at $2.05 per share.
- Quantity and value: 2,904 shares sold, proceeds ≈ $5,953.
- Transaction type: Reported as an open market or private sale (code S).
- Holdings after transaction: The filing excerpt does not list a single consolidated post-sale share total; the report includes multiple RSU and option grant schedules (see footnotes).
- Notable footnotes:
- F1–F4 describe multiple RSU grants with staggered vesting schedules (e.g., 30,820 RSUs vesting by 7/15/2026; 35,480 RSUs vesting through 12/31/2027; 25,000 RSUs vesting 12/31/2026).
- F5 outlines a stock option vesting schedule that began 10/1/2022.
- Exhibit 24.1: Power of Attorney referenced.
- Timeliness: Form 4 was filed 2026-06-01 reporting the 2026-05-28 transaction. The provided excerpt does not indicate a late filing flag.
Context
A sale by an executive is often routine (e.g., liquidity, tax withholding, diversification) and does not by itself indicate a change in outlook. The filing shows the insider holds or will receive additional shares as they vest under multiple RSU grants and has options with staged vesting; those ongoing vesting schedules mean more shares may become available to the insider over time.
Insider Transaction Report
Form 4
Freightos LtdCRGO
Alventosa Abril Enric
Chief Technology Officer
Transactions
- Sale
Ordinary Shares
[F1]2026-05-28$2.05/sh−2,904$5,953→ 26,746 total
Holdings
- 34,133
Ordinary Shares
[F2][F3] - 25,000
Ordinary Shares
[F2][F4] - 35,181
Stock Option (right to buy)
[F2]Exercise: $4.17From: 2025-04-01Exp: 2031-04-27→ Ordinary Shares (35,181 underlying) - 58,048
Stock Option (right to buy)
[F2]Exercise: $4.17From: 2026-01-01Exp: 2032-02-17→ Ordinary Shares (58,048 underlying) - 42,217
Stock Option (right to buy)
[F2][F5]Exercise: $8.44Exp: 2032-11-02→ Ordinary Shares (42,217 underlying)
Footnotes (5)
- [F1]The ordinary shares reported in this row consist of shares underlying restricted share units ("RSUs") granted by the Issuer to the Reporting Person that began vesting (and settling for underlying ordinary shares) on July 15, 2023. The 30,820 RSUs originally granted vest in accordance with the following schedule: 33.33% of those RSUs vested upon the one-year anniversary of the vesting commencement date, and the remainder of those RSUs vest equally on a quarterly basis over the following eight quarters (8.3325% per quarter) such that all such 30,820 RSUs (reduced by any RSUs for which underlying shares have been sold) will be vested by the three-year anniversary of the vesting commencement date (July 15, 2026).
- [F2]There were no transactions effected in respect of the securities reported in this row, and the holdings in this row are being included for informational purposes only.
- [F3]The ordinary shares reported in this row consist of shares underlying RSUs granted by the Issuer to the Reporting Person that began vesting (and settling for underlying ordinary shares) on July 15, 2024. The 35,480 RSUs originally granted vest in accordance with the following schedule: 33.33% of the RSUs vested upon the one-year anniversary of the vesting commencement date and the remaining RSUs vest equally on a quarterly basis over the following ten quarters (6.66% per quarter) such that all such 35,480 RSUs (reduced by any RSUs for which underlying shares are sold) will be vested by December 31, 2027.
- [F4]The ordinary shares reported in this row consist of shares underlying 25,000 RSUs granted by the Issuer to the Reporting Person that began vesting (and settling for underlying ordinary shares) on March 13, 2025 and that vest (and settle for underlying ordinary shares) in their entirety on December 31, 2026.
- [F5]The stock options reported in this row granted by the Issuer to the Reporting Person began vesting (and becoming exercisable for underlying ordinary shares) on October 1, 2022, in accordance with the following schedule: 25% of the options vested upon the one-year anniversary of the vesting commencement date and the remaining options vest equally on a quarterly basis over the following twelve quarters (6.125% per quarter) such that all such options will be vested by the four-year anniversary of the vesting commencement date.
Signature
/s/ Max Sitnick, Attorney-in-fact|2026-06-01